Amgen (AMGN) Treasury Shares (2009 - 2011)
Amgen (AMGN) posted Treasury Shares of $3.0 billion for Q3 2011, up 304.97% on a QoQ basis from $745.0 million in Q2 2011, and up 16.31% year-over-year from $2.6 billion in Q3 2010.
Analysis
Amgen (AMGN) Treasury Shares (2009 - 2011) Analysis & Trends
Amgen has reported Treasury Shares for 3 years, with the latest figure at $3.0 billion in Q3 2011.
- On a quarterly basis, Treasury Shares rose 16.31% year-over-year to $3.0 billion in Q3 2011; TTM through Sep 2011 was $3.0 billion, a 16.31% increase from a year earlier, with the FY2010 full-year figure at $3.8 billion, up 18.02% from the prior year.
- Treasury Shares was $3.0 billion for Q3 2011 at Amgen, up from $745.0 million in the prior quarter.
- The five-year high for Treasury Shares was $3.8 billion in Q4 2010, with the low at $14.0 million in Q1 2011.
- Average Treasury Shares over 3 years is $2.1 billion, with a median of $2.1 billion recorded in 2009.
- The sharpest annual moves came in 2010 and 2011: Treasury Shares climbed 29.89% in 2010, then tumbled 99.12% in 2011.
- Over 3 years, Treasury Shares stood at $3.2 billion in 2009, then advanced by 18.02% to $3.8 billion in 2010, then declined by 20.31% to $3.0 billion in 2011.
- The last three Treasury Shares figures came in at $3.0 billion (Q3 2011), $745.0 million (Q2 2011), and $14.0 million (Q1 2011), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2011 | 3.02 Bn |
| Sep 30, 2011 | 3.02 Bn |
| Jun 30, 2011 | 745.00 Mn |
| Jun 30, 2011 | 745.00 Mn |
| Mar 31, 2011 | 14.00 Mn |
| Mar 31, 2011 | 14.00 Mn |
| Dec 31, 2010 | 3.79 Bn |
| Dec 31, 2010 | 3.79 Bn |
| Sep 30, 2010 | 2.59 Bn |
| Sep 30, 2010 | 2.59 Bn |
| Jun 30, 2010 | 2.30 Bn |
| Jun 30, 2010 | 2.30 Bn |
| Mar 31, 2010 | 1.59 Bn |
| Mar 31, 2010 | 1.59 Bn |
| Dec 31, 2009 | 3.21 Bn |
| Dec 31, 2009 | 3.21 Bn |
| Sep 30, 2009 | 2.00 Bn |
| Sep 30, 2009 | 2.00 Bn |
| Jun 30, 2009 | 2.00 Bn |
| Jun 30, 2009 | 2.00 Bn |